Stock Analiz

Precigen, Inc. (PGEN) stock forecast and price target

Price $4.54 · data as of November 13, 2026

12-month price target

Average target$13.67
Upside / downside+201.0%
Analysts3
ConsensusBuy
Low $11.00Average $13.67High $18.00

Gold marker: average target · white marker: today’s price ($4.54)

Analyst ratings

Strong buy 1Buy 2Hold 1Sell 0Strong sell 0

Earnings and revenue estimates

PeriodEPS estimateEPS growthRevenue estimate
Current fiscal year
ends December 31, 2026
$0.24—$240M
Next fiscal year
ends December 31, 2027
$0.62—$442M
Next quarter
ends December 31, 2026
$0.11—$88M
Quarter after
ends March 31, 2027
$0.14—$93M

Consensus of the analysts covering Precigen, updated daily. In the last 30 days 2 estimates were raised and 1 lowered.

Our model vs. Wall Street

Analysts see 201.0% upside over 12 months. Our discounted cash flow model with moderate assumptions puts Precigen’s intrinsic value about 88% below today’s market value, and it scores 0.4 out of 5 on our checks. Price targets follow sentiment; a DCF follows cash. When both point the same way the signal is stronger. Try your own assumptions.

Frequently asked questions

What is the Precigen stock price target?

The average 12-month target from 3 analysts is $13.67, 201.0% above the current price of $4.54 Targets range from $11.00 to $18.00.

Is Precigen a buy according to analysts?

The consensus rating is “Buy” (1 strong buy, 2 buy, 1 hold). Ratings are opinions, not guarantees; this is not investment advice.

How much is Precigen expected to earn?

Analysts expect EPS of $0.24 for the fiscal year ending December 31, 2026 and $0.62 the year after.

Analyst consensus estimates and price targets, updated daily. Forecasts can be wrong; this is information, not investment advice.